OncoMax presented its research at the 5th European Multidisciplinary Meeting for Urological Cancer (EMUC), which was held on 15-17 November 2013 in Marseille, France. Dr. Ilya Tsimafeyeu, a scientific advisor of OncoMax, has received a special award for the best research “FIRST PRIZE” for his study "FGF- and VEGF-dependent angiogenesis and its targeting"
The company Photonics, invested by Maxwell Biotech Venture Fund and RVC Seed Fund, has received minigrant of Skolkovo Foundation in the amount of 5 million rubles for initial proof of principle of a concept of gingival and aveolar bone regeneration using a new method of oral tissue treatment with LPM technology, which will be implemented in a new dental laser for hard tissue surgery by Photonics
Technopark TV Program available in English
The investment comm­­ittee of RVC Biofund has approved the investment in Andrus Reo, a recently established startup which will conduct phase III clinical trials for an antineoplastic drug in Russia and the CIS. The Reovirus based anti-cancer drug, which is being jointly developed with Oncolytics Biotech Inc. of Canada, targets the treatment of head and neck malignant tumors as well as pancreatic cancer
Technopark TV Program now available in English
RVC launches its official page on the social network Google+

Search by name:

Search by date:

Select date in calendar
Select date in calendar